Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-24-016346
Filing Date
2024-12-18
Accepted
2024-12-18 09:30:27
Documents
18
Period of Report
2024-10-04
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A dwtx-20241004x8ka.htm   iXBRL 8-K/A 49108
2 EX-23.1 dwtx-20241004xex23d1.htm EX-23.1 2955
3 EX-99.1 dwtx-20241004xex99d1.htm EX-99.1 448332
4 EX-99.2 dwtx-20241004xex99d2.htm EX-99.2 361633
5 EX-99.3 dwtx-20241004xex99d3.htm EX-99.3 353894
6 GRAPHIC dwtx-20241004xex99d2001.jpg GRAPHIC 3169
  Complete submission text file 0001558370-24-016346.txt   1436976

Data Files

Seq Description Document Type Size
7 EX-101.SCH dwtx-20241004.xsd EX-101.SCH 3400
8 EX-101.LAB dwtx-20241004_lab.xml EX-101.LAB 15930
9 EX-101.PRE dwtx-20241004_pre.xml EX-101.PRE 10045
20 EXTRACTED XBRL INSTANCE DOCUMENT dwtx-20241004x8ka_htm.xml XML 4854
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Dogwood Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39811 | Film No.: 241557841
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)